Three Princess Margaret doctors recognized with a 2018 Canadian Cancer Society Award for Excellence

The Canadian Cancer Society announced its 2018 Awards for Excellence recipients to recognize individuals for their outstanding work in identifying ways to prevent, diagnose and treat cancer, which ultimately brings us closer to finding a cure.
doctors-collage-1.jpg                                                                       Dr. Rodger Tiedemann, left, Dr. Pamela Ohashi, Dr. Gelareh Zadeh

Congratulations to The Princess Margaret’s Drs. Pamela Ohashi, Rodger Tiedemann, and Gelareh Zadeh for receiving  an award for making a valuable contribution to cancer research.

Dr. Pamela Ohashi is the recipient of the Robert L. Noble Prize. Dr. Ohashi is a world-renowned leader in Immunotherapy. With her research and leadership, Dr. Ohashi’s work has helped us understand how the immune system can be used to treat cancer.

Dr. Rodger Tiedemann is the co-recipient of the William Rawls Prize. Dr. Tiedemann has led a breakthrough study on the existence of a population of atypical plasma cells that allow multiple myeloma to become resistant to a key chemotherapy drug.

Dr. Gelareh Zadeh is the co-recipient of the William Rawls Prize. Dr. Zadeh is the head of Surgical Oncology at the Princess Margaret. Her clinical practice and research has made strides in how we view brain tumours, such as glioblastomas, meningiomas, and Schwannomas.

“With 1 in 2 Canadians expected to be diagnosed with cancer in their lifetime, the research advancements made by these dedicated scientists have benefitted, and will continue to benefit, millions of people,” says Dr. Judy Bray, Vice President of Research at the Canadian Cancer Society. “We believe these researchers will continue to accelerate progress against cancer, helping Canadians to live longer, fuller and healthier lives.”